A study on soy-based food supplements as medical nutriceutical therapy in reversing lipid abnormalities
was conducted by:
Cardiovascular diseases rank number one in causing death globally.
Soy and fibers have been proven to improve lipid abnormalities and therefore, benefit health.
To determine the efficacy and safety of soy based oral food supplements Reliv Now and Fibrestore in the management of lipid abnormalities.
60-day multi-center, prospective, randomized, double-blind, placebo-controlled trial on soy-based food supplements.
Adults (_>18 years old) with lipid abnormalities, which may be any of the following; high cholesterol, tryglicerides, LDL.
Decrease in average cholesterol level after 60 days was seen only in Reliv Now and Fibrestore.
Decrease in LDL level after 60 days was seen only in Reliv Now & Fibrestore.
Triglyceride level was reduced by FibRestore after 60 days.
had greater reduction in fasting
level after 60 days
& FibRestore® showed reduction in
blood uric acid
levels after 60 days
Changes in average weight after 60 days
& FibRestore® showed greater
in cholesterol and triglycerides among
& FibRestore® showed greater reduction
cholesterol among overweight subjects
® and FibRestore®:
Reduced average cholesterol by 14%
Reduced average LDL by 18% and 8%, respectively
Reduced average triglycerides by 1.2% and 12.4%,
Reduced average uric acid by 10.4% and 16.7%,
Greater reduction in cholesterol and triglycerides
diabetic or overweight individuals
This study proved that Relìv
® Now and
® are effective food supplements in
correcting lipid abnormalities and hence, may help in lowering the risk for cardiovascular disease.